CINECA IRIS Institutional Research Information System

RAPA, IDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.099
EU - Europa 2.254
AS - Asia 1.472
SA - Sud America 81
AF - Africa 39
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.986
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.027
CN - Cina 833
IT - Italia 589
IE - Irlanda 241
SE - Svezia 241
DE - Germania 226
FR - Francia 178
UA - Ucraina 134
FI - Finlandia 126
IN - India 118
SG - Singapore 101
GB - Regno Unito 94
KR - Corea 92
JP - Giappone 86
VN - Vietnam 84
PL - Polonia 80
AT - Austria 67
ES - Italia 61
CA - Canada 56
DK - Danimarca 39
BR - Brasile 36
BE - Belgio 34
TR - Turchia 34
NL - Olanda 33
AU - Australia 30
HK - Hong Kong 28
SN - Senegal 28
RU - Federazione Russa 21
AR - Argentina 18
CL - Cile 17
GR - Grecia 17
CH - Svizzera 15
IL - Israele 15
RO - Romania 15
MX - Messico 14
NO - Norvegia 10
SA - Arabia Saudita 10
TW - Taiwan 10
UZ - Uzbekistan 10
CZ - Repubblica Ceca 8
ID - Indonesia 8
MY - Malesia 7
QA - Qatar 7
TH - Thailandia 7
EU - Europa 6
PT - Portogallo 6
HR - Croazia 5
HU - Ungheria 5
IR - Iran 5
PE - Perù 5
PH - Filippine 5
NZ - Nuova Zelanda 4
EG - Egitto 3
IQ - Iraq 3
CO - Colombia 2
EC - Ecuador 2
NG - Nigeria 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
FJ - Figi 1
GT - Guatemala 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MW - Malawi 1
NP - Nepal 1
RS - Serbia 1
SC - Seychelles 1
SD - Sudan 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
Totale 7.986
Salva come PNG Salva come JPEG
Città #
Chandler 498
Beijing 362
Fairfield 305
Houston 287
Dublin 236
Ann Arbor 223
Ashburn 217
Torino 161
Woodbridge 161
Wilmington 139
Redwood City 136
Seattle 124
Pisa 109
Nyköping 103
Cambridge 102
Dearborn 97
Villeurbanne 93
Princeton 76
Fremont 75
Medford 73
Jacksonville 71
Dong Ket 69
Vienna 66
Warsaw 65
Singapore 60
Shanghai 55
New York 44
Nanjing 39
Milan 36
Boston 35
Boardman 34
Guangzhou 34
Turin 31
Hangzhou 26
Brussels 24
Pune 24
Munich 23
San Diego 23
Los Angeles 22
Chengdu 20
Helsinki 20
Norwalk 19
Düsseldorf 18
Kunming 18
Wuhan 18
Changsha 17
Istanbul 16
Madrid 15
Zhengzhou 15
Phoenix 14
Shenyang 14
Tokyo 14
Washington 14
Bethesda 13
Erlangen 13
Hefei 13
León 13
Silver Spring 13
London 12
Eitensheim 11
Rome 11
Santiago 11
Seoul 11
Toronto 11
Barcelona 10
Zurich 10
Buffalo 9
Falls Church 9
Hebei 9
Tappahannock 9
Xian 9
Bangalore 8
Hong Kong 8
Padova 8
Denver 7
Jinan 7
Mountain View 7
Oslo 7
Rzeszów 7
Suzhou 7
Upper Marlboro 7
Berlin 6
Duncan 6
Gurgaon 6
Lyon 6
Mexico 6
Mont-saint-aignan 6
Napoli 6
Nürnberg 6
Rio de Janeiro 6
Rotterdam 6
Stanford 6
Taipei 6
Utrecht 6
Vigo 6
Amsterdam 5
Brisbane 5
Canberra 5
Central District 5
Chicago 5
Totale 4.969
Salva come PNG Salva come JPEG
Nome #
IMPACT OF PREGNANCY ON PROGNOSIS OF DIFFERENTIATED THYROID CANCER: CLINICAL AND MOLECULAR FEATURES. 428
RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact 327
Molecular and Histological Changes in Post-Treatment Biopsies of Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Study 315
Functional Role and Prognostic Significance of CD157 in Ovarian Carcinoma 304
Therapeutic Biomarkers in Lung Neuroendocrine Neoplasia 291
microRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations 290
Thymidylate synthase is functionally associated with ZEB1 and contributes to the epithelial-to-mesenchymal transition of cancer cells 284
RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization 242
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma. 235
Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. 220
Personalized therapeutic strategies in HER2-driven gastric cancer 219
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 203
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 195
H-RAS mutations are restricted to sporadic pheochromocytomas lacking specific clinical or pathological features data from a multi-institutional series 183
mTORC1 Complex is Significantly Over-Activated in SDHX-Mutated Paragangliomas 182
CD157 enhances malignant pleural mesothelioma aggressiveness and predicts poor clinical outcome. 173
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung. 171
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer 161
Impact of non-small-cell lung cancer-not otherwise specified immunophenotyping on treatment outcome. 127
Mechanical phenotyping of cells and extracellular matrix as grade and stage markers of lung tumor tissues 126
Biological role and clinical significance of CD157 in epithelial ovarian cancer 125
Ribonucleotide Reductase Large Subunit (RRM1) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer. 120
Biological role, clinical significance and potential therapeutic applications of CD157 in ovarian cancer 119
CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells 112
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine 106
Clinical and biological significance of CD157 in malignant pleural mesothelioma 105
CD157: A New Prognostic and/or Predictive Marker in Ovarian Cancer? A Retrospective Study 105
Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma 105
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 104
CD157 is a novel prognostic marker of malignant pleural mesothelioma involved in the control of tumor aggressiveness 99
Androgen deprivation modulates gene expression profile along prostate cancer progression 94
Clinical and biological significance of CD157 in ovarian carcinoma 92
CD157 CONTROLS PERITONEAL DISSEMINATION AND INVASION OF OVARIAN CARCINOMA AND IS A MOLECULAR PREDICTOR OF POOR CLINICAL OUTCOME 92
CD157 as a potential pleural effusion biomarker for malignant mesothelioma 89
Images in Endocrine Pathology: Unique Composite Adrenal Adenomatoid Tumor, Ganglioneuroma, Myelolipoma, and Cortical Nodular Hyperplasia 87
Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma 86
Identification of MicroRNAs Differentially Expressed in Lung Carcinoid Subtypes and Progression 83
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids 83
Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia. 81
Dissecting morphological and molecular heterogeneity in adrenocortical carcinoma 78
Multiple Assays to Determine Methylguanine-Methyltransferase Status in Lung Carcinoids and Correlation with Clinical and Pathological Features 78
Somatostatin receptor type 2A immunohistochemistry in neuroendocrine tumors: a proposal of scoring system correlated with somatostatin receptor scintigraphy 77
CD157: A NEW PROGNOSTIC MARKER IN OVARIAN CANCER 74
Tumor/Stromal caveolin-1 expression patterns in pleural mesothelioma define a subgroup of the epithelial histotype with poorer prognosis 73
Proton pump inhibitors promote the growth of androgen-sensitive prostate cancer cells through ErbB2, ERK1/2, PI3K/Akt, GSK-3β signaling and inhibition of cellular prostatic acid phosphatase 73
Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data 70
Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth 67
Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer 66
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas 65
Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases 63
mTOR pathway activation in multiple myeloma cell lines and primary tumour cells: pomalidomide enhances cytoplasmic-nuclear shuttling of mTOR protein 63
Human ASH-1 Promotes Neuroendocrine Differentiation in Androgen Deprivation Conditions and Interferes With Androgen Responsiveness in Prostate Cancer Cells. 60
Poorly differentiated thyroid carcinoma: diagnostic features and controversial issues 59
Squamous cell carcinoma of the lung compared with other histotypes shows higher messenger RNA and protein levels for thymidylate synthase 59
Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth 59
Differential expression profiles of cell-to-matrix-related molecules in adrenal cortical tumors: Diagnostic and prognostic implications 58
Human ASH1 expression in prostate cancer with neuroendocrine differentiation 57
[Immunohistochemistry in thyroid needle aspiration samples] 54
Expression and pharmacological inhibition of thymidilate synthase and Src kinase in non-small cell lung cancer. 50
Thymidylate synthase expression in gastroenteropancreatic and pulmonary neuroendocrine tumors 48
High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs 40
Proposal of a Panel of Genes Identified by miRNA Profiling as Candidate Prognostic Biomarkers in Lung Carcinoids 40
Primary lung adenocarcinoma in three adolescent patients affected by bone sarcomas 38
Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition 34
Human achaete-scute homolog-1 expression in neuroendocrine breast carcinoma. 32
Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer 32
The Oncocytic Variant of Poorly Differentiated Thyroid Carcinoma Shows a Specific Immune-Related Gene Expression Profile 30
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer 29
Targeting the multidrug transporter Patched potentiates chemotherapy efficiency on adrenocortical carcinoma in vitro and in vivo. 23
Galectin-3 immunohistochemical detection in the differential diagnosis of parathyroid lesions 22
Molecular Subtypes of Extra-pulmonary Neuroendocrine Carcinomas Identified by the Expression of Neuroendocrine Lineage-Specific Transcription Factors 10
MicroRNA profiling predicts positive nodal status in papillary thyroid carcinoma in the preoperative setting 5
Totale 8.249
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.672
article - articoli 0
book - libri 0
conference - conferenze 2.186
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.858
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.432 66 67 76 170 96 250 166 137 122 145 62 75
2020/20211.034 69 84 80 65 99 89 84 61 94 97 53 159
2021/20221.161 87 87 70 96 65 59 62 82 48 83 237 185
2022/20231.522 127 108 60 148 155 340 98 113 185 44 77 67
2023/2024828 91 125 43 52 68 117 39 85 14 56 62 76
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 8.249